SCHEDULE: BlackRock Boosts Eastman Chemical Stake to 11.9%
Schedule 13G Amendment
BlackRock, Inc. has reported an increased beneficial ownership of 11.9% in Eastman Chemical Co., holding over 13.5 million shares.
Summary
- BlackRock, Inc. beneficially owns 13,598,433 shares of Eastman Chemical Co. common stock.
- This represents 11.9% of the class of securities.
- BlackRock, Inc. holds sole voting power over 13,254,753 shares.
- BlackRock, Inc. holds sole dispositive power over 13,598,433 shares.
- No shared voting or dispositive power is reported.
- iShares Core S&P Small-Cap ETF holds more than 5% of the total outstanding common stock of Eastman Chemical Co.
- BlackRock Fund Advisors, a subsidiary of BlackRock, Inc., beneficially owns 5% or greater of the outstanding shares of the security class.
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership, providing no performance or forward-looking statements for the issuer, Eastman Chemical Co. The sentiment is neutral.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney revoked by BlackRock, Inc. |
| 2025-01-21 | Execution date of the new Power of Attorney by BlackRock, Inc. |
| 2025-11-30 | Date of event which requires filing of this statement |
| 2025-12-04 | Signature date of the Schedule 13G filing by BlackRock, Inc. |
Keywords
BlackRock, Eastman Chemical, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.